Volume 91 Issue 42 | p. 9 | News of The Week
Issue Date: October 21, 2013 | Web Date: October 17, 2013

Venture Philanthropy Backs Diabetes Research Start-ups

Partnership: Diabetes advocacy group joins forces with PureTech to spur treatment-focused firms
Department: Business
Keywords: venture philanthropy, biotechs, pharmaceuticals, start-ups

Patient advocacy groups are continuing to push the boundaries of venture philanthropy, which enables them to invest in for-profit firms in order to reach their charitable goals. JDRF, a type 1 diabetes-focused nonprofit, and life sciences development firm PureTech Ventures will launch T1D Innovations, a financial vehicle for the creation of drug discovery companies that target type 1 diabetes.

In recent years, many disease advocacy groups have moved . . .

To view the rest of this content, please log in with your ACS ID.



 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society